Novanta (NASDAQ:NOVT – Get Free Report) and Eltek (NASDAQ:ELTK – Get Free Report) are both technology companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.
Risk & Volatility
Novanta has a beta of 1.72, meaning that its stock price is 72% more volatile than the S&P 500. Comparatively, Eltek has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Novanta and Eltek, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Novanta | 0 | 2 | 1 | 0 | 2.33 |
| Eltek | 1 | 0 | 0 | 0 | 1.00 |
Insider and Institutional Ownership
98.3% of Novanta shares are owned by institutional investors. Comparatively, 64.6% of Eltek shares are owned by institutional investors. 1.2% of Novanta shares are owned by insiders. Comparatively, 72.0% of Eltek shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Earnings & Valuation
This table compares Novanta and Eltek”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Novanta | $1.03 billion | 5.01 | $53.83 million | $1.56 | 87.39 |
| Eltek | $51.79 million | 1.01 | $830,000.00 | ($0.91) | -8.53 |
Novanta has higher revenue and earnings than Eltek. Eltek is trading at a lower price-to-earnings ratio than Novanta, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Novanta and Eltek’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Novanta | 6.00% | 10.83% | 7.53% |
| Eltek | -12.66% | -13.57% | -9.01% |
Summary
Novanta beats Eltek on 13 of the 14 factors compared between the two stocks.
About Novanta
Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products. The Vision segment offers a range of medical grade technologies, including medical insufflators, pumps and related disposables, surgical displays and operating room integration technologies, optical data collection and machine vision technologies, radio frequency identification technologies, thermal printers, spectrometry technologies, and embedded touch screen solutions. The Precision Motion segment includes optical encoders, precision motor and motion control technology, air bearing spindles, and precision machined components to customers. The company was founded in 1968 and is headquartered in Bedford, MA.
About Eltek
Eltek Ltd. manufactures, markets, and sells printed circuit boards (PCBs) in Israel, Europe, North America, India, the Netherlands, and internationally. It offers a range of custom designed PCBs, including rigid, double-sided and multi-layer PCBs, and flexible circuitry boards. The company also provides high density interconnect, flex-rigid, and multi-layered boards. It primarily serves medical technology, defense and aerospace, industrial, telecom, and networking equipment industries, as well as contract electronic manufacturers. The company markets and sells its products primarily through direct sales personnel, sales representatives, and PCB trading and manufacturing companies. Eltek Ltd. was incorporated in 1970 and is headquartered in Petah Tikva, Israel. Eltek Ltd. operates as a subsidiary of Nistec Golan Ltd.
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
